Marker Therapeutics (MRKR) Q4 2025 Earnings

14NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-0.53
-0.39
-0.26
-0.12

Details

Expected EPS
-0.36
Actual EPS
-0.12
Surprise EPS
0.24
Surprise Percent
+66.67%

Description

Marker Therapeutics (MRKR) has reported earnings of -0.12 per share for Q4 2025.

0 Comments

Share your thoughts